ifenprodil has been researched along with Hypoxia-Ischemia, Brain in 1 studies
ifenprodil: NMDA receptor antagonist
Hypoxia-Ischemia, Brain: A disorder characterized by a reduction of oxygen in the blood combined with reduced blood flow (ISCHEMIA) to the brain from a localized obstruction of a cerebral artery or from systemic hypoperfusion. Prolonged hypoxia-ischemia is associated with ISCHEMIC ATTACK, TRANSIENT; BRAIN INFARCTION; BRAIN EDEMA; COMA; and other conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yao, H | 1 |
| Liu, W | 1 |
| Liao, H | 1 |
| Sheng, T | 1 |
| Chen, P | 1 |
| Zhou, H | 1 |
| Pan, Y | 1 |
| Xie, J | 1 |
| Zhang, Q | 1 |
| Zou, Z | 1 |
| Chen, Z | 1 |
1 other study available for ifenprodil and Hypoxia-Ischemia, Brain
| Article | Year |
|---|---|
Geniposide attenuates postischemic long-term potentiation via GluN2A.
Topics: Animals; Apoptosis; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Hippocamp | 2021 |